HALEY JONES: Open Payments
NPI 1689305260 · RUSTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 35 payments from 9 companies in 2025. Trend: 2023 $51 · 2024 $641 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $147 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Novo Nordisk Inc | 2 | $40 |
| Astellas Pharma US Inc | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| PFIZER INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Exact Sciences Corporation | 1 | $17 |
Products named: CAPLYTA, VRAYLAR, QULIPTA, Auvelity, Ozempic, Veozah, Kerendia, UBRELVY.
Industry payments across LA — which companies pay providers there.
